Innovative blood test boosts accuracy of lung cancer screening

FHS
June 11, 2024
9:40 am

A blood-based, cell-free deoxyribonucleic acid (cfDNA) fragmentome assay for lung cancer detection.

LUCARG-39D by Legend Biotech for B-Cell Non-Hodgkin Lymphoma: Likelihood of Approval

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes

July 4, 2024

ChatGPT Takes on the Neuro Boards

ChatGPT significantly outperformed humans on a mock version of the American Board of Psychiatry and Neurology (ABPN) boards. ChatGPT-4, the newer version of Open AI’s

December 9, 2023

More Newborns Intubated on First Try With Video Laryngoscopy

Video laryngoscopy for the urgent intubation of neonates led to higher rates of success on the first attempt than direct laryngoscopy, a single-center randomized trial

May 7, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.